Open enrollment looks like the moment women’s health gets decided. It isn’t. By the time an employee logs into a portal in November, the formulary is locked, the vendor contracts are signed, and the network is built. The real decision happened in a budget meeting five or six months earlier, and almost nobody in that room called it a women’s health decision.

That’s the gap I want employers to close. Not the enrollment window. The budget window that precedes it.

The Decision Already Happened

Renewals, procurement cycles, and Q2 budget conversations set the terms of coverage for the following plan year. Whether fertility benefits survive another budget cut, whether menopause support gets funded, whether an employee with PMOS (formerly classified as PCOS) has an actual pathway to care instead of five disconnected referrals. All of that gets locked in before anyone drafts the enrollment email.

I’ve been saying this for years: women’s health is entire-body health. Spread across the full working lifespan, women’s health rarely fits into a single line item the way fertility benefits do. That’s exactly why it tends to lose out in a budget meeting to things that fit more cleanly, like a benefit with a clean cost model and a vendor with a polished pitch.

That’s a budgeting problem, and budgeting problems get fixed by moving the audit earlier, not by writing a better enrollment brochure.

Coverage on Paper Isn’t Coverage in Practice

Menopause support is becoming more mainstream in benefits packages. In Business Group on Health’s 2026 Employer Health Care Strategy Survey, 58% of employers said they will provide menopause support programs, up from 28% two years earlier. That’s real progress. It’s also the wrong thing to celebrate on its own. A program existing and a program working are not the same claim, and most employers are still only answering the first one.

An employer can technically cover menopause because employees have access to a primary care physician or an OB-GYN. That tells you nothing about whether those clinicians have menopause training, whether appointments are available inside a reasonable window, or whether the treatments employees need are on the formulary.

PMOS fails the same test. Coverage scattered across primary care, gynecology, endocrinology, and nutrition looks comprehensive in a benefits package. In practice, the employee stitches it together herself. A benefit that requires a full-time coordinator to use isn’t functioning as a benefit. 

Employers should ask one practical question: what happens when an employee tries to use this benefit? Check referral and prior authorization requirements, network adequacy, and out-of-pocket cost before counting something as covered. A covered service that’s practically inaccessible is not meaningful coverage.

Buy Infrastructure, Not Solutions by Life Event

Benefits have traditionally been organized around moments: pregnancy, childbirth, infertility. Women don’t experience health that way. Someone with PMOS may need care from adolescence through her reproductive years and ongoing monitoring for metabolic and cardiovascular risk. Menopause tends to hit during the exact years many women are stepping into senior leadership roles.

But that doesn’t mean buying a platform for every condition. A fertility platform, a menopause app, and a PMOS program purchased separately, without being connected, replaces one fragmented system with three fragmented systems that each send an invoice.

The question that actually matters is whether the benefits architecture connects the stages of a woman’s working life. If it doesn’t, employers aren’t building infrastructure. They’re collecting vendors.

Make Vendors Prove the Benefits Work

Women’s health has attracted more companies, innovation, and capital. That’s necessary and overdue. But employers shouldn’t confuse a growing market with a mature one. 

Ask every vendor the questions that matter: who actually uses this? Does utilization translate into access, not just logins? What happens to the program after the pilot ends and the budget line has to justify itself on its own? 

That last question separates durable healthcare infrastructure from a program that disappears the moment an innovation budget changes.

Employers are projecting a median 9% increase in healthcare costs for 2026 before any plan design changes (Business Group on Health). Under that pressure, a benefit has to earn its place with more than a good pitch. Not every worthwhile intervention shows up as an immediate medical-cost saving, and that’s fine. Value has more inputs than a single ROI line. Track access, appropriate care, utilization, absenteeism, disability claims, retention, and total cost together, or you’re grading on the wrong scorecard.

Audit the Data You Already Own

Most companies don’t need new research to find the gaps. They need to read the claims, utilization, absenteeism, prescription patterns, and exit data already sitting in their own systems, broken out by age and life stage where possible.

Low utilization gets misread constantly. It’s easy to assume it means low demand. But it usually means bad access: no appointments, an inadequate network, or out-of-pocket costs that make a technically covered benefit functionally unusable. Read the data before you cut the program, not after, and do it in the same budget cycle as the renewal decision, months before open enrollment.

Put This on the CFO’s Desk, Not the DEI Budget

Women’s health doesn’t belong in a resource group, a side initiative championed by one executive, or the DEI budget. It belongs in the core healthcare strategy, reviewed with the same rigor as any other major line item. 

There’s momentum here worth building on. Business Group on Health’s 2026 survey found 58% of employers plan to expand preventive care for women, 55% will cover postpartum depression treatment, and 36% will cover doula services. Employers are moving. The open question is whether what they’re funding actually connects into something an employee can use.

The CFO should own the cost model. The CHRO should own the design. Benefits leaders should own the vendor diligence. All three need to be in the room before the contracts get signed, because once formularies are set and enrollment materials go to print, the window closes for another year.

The average age of women in menopause is 52 in the U.S., squarely inside the years they’re reaching senior leadership. That’s the talent the business is trying to keep.

Open enrollment will always be the reveal. The real work—the budget audit, the vendor diligence, the lifecycle design—has to happen now, months before anyone opens a portal. Women’s health gets discussed on stages all year. In the fall during enrollment, somebody has to put it in the benefits package. The next era of employer-sponsored women’s health will be defined by whether those benefits add up to a healthcare system women can actually use.